[1] Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect. Genet. Evol. 2020;79:104212.
[2] Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination,and pathogenesis of coronaviruses. Trends. Microbiol. 2016;24:490–502.
[3] Burrell C, Howard C, Murphy F. Fenner and White’s medical virology. 5th ed.United States: Academic Press. 2016.
[4] Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation andepidemiology of 2019 novel coronavirus: implications for virus origins andreceptor binding. Lancet. 2020;395:564-574.
[5] Li X,Wang LW, Yang SN, Yang F, Xiang LK, Zhu JL. Clinical characteristics of 25 death cases infected with COVID-19 pneumonia: a retrospective review of medical records in a single medical center, Wuhan, China. medRxiv. 2020;94:128-132.
[6] Fan Z, Chen L, Li J, Cheng X, Yang J, Tian C, Zhang Y, Huang S, Liu Z, Cheng J. Clinical Features of COVID-19-Related Liver Functional Abnormality. Clin Gastroenterol Hepatol. 2020;18(7):1561-1566.
[7] Ma L, Xie W, Li D, Shi L, Mao Y, Xiong Y, et al. Effect of SARS-CoV-2 infection upon male gonadal function: a single center-based study. medRxiv. 2020.
[8] Symptoms of Coronavirus (COVID-19) https://www.cdc.gov/coronavirus/2019-ncov/downloads/COVID19- symptoms.pdf
[9] Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation andepidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020.
[10] World Health Organization. COVID-19 Weekly Epidemiological Update. (2021). Situation Report till 04 may. 2021.
[11] Lu, H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020;14(1):69-71.
[12] Rehan M, Shafiullah. Medicinal plant-based saponins targeting of COVID-19 Mpro (in silico). Traditional Medicine Research. 2021;6(3):24.
[13] Jin Z, Du X, Xu Y, et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. bioRxiv. 2020;02(26):964882.
[14] Chauhan A, Kalra S. Identification of potent COVID-19 main protease (Mpro) inhibitors from flavonoids. Research Square. 2020.
[15] Hussain H, Ivan R, Green, Saleem M, Raza ML, Nazir M. Therapeutic Potential of Iridoid Derivatives: Patent Review. Inventions. 2019;4:29.
[16] Guo S, Bao L, Li C, et al. Antiviral activity of iridoid glycosides extracted from Fructus Gardeniae against influenza A virus by PACT-dependent suppression of viral RNA replication. Sci. Rep. 2020;10:1897.
[17] Oh SR, Lee MY, Ahn K. Suppressive effect of verproside isolated from Pseudolysimachion longifolium on airway inflammation in a mouse model of allergic asthma. Int. Immunopharmacol. 2006;6:978–986.
[18] Ding ST, Liu HT, Li WM. Protective effects of geniposide on human umbilical vein endothelial cell injury induced by H2O2 in vitro. Chin. Pharmacol. Bull. 2009;25:725–729.
[19] Gao BB, She GM, She DM. Chemical Constituents and Biological Activities of Plants from the Genus Ligustrum. Chem. Biodivers. 2013;10:96–128.
[20] Toriizuka K, Kamiki H, Ohmura NY, et al. Anxiolytic effect of Gardeniae Fructus-extract containing active ingredient from Kamishoyosan (KSS), a Japanese traditional Kampo medicine. Life Sci. 2005;77:3010–3020.
[21] Chen JL, Blanc P, Stoddart CA, et al. New Iridoids from the Medicinal Plant Barleria, prionitis with Potent Activity against Respiratory Syncytial Virus. J. Nat. Prod. 1998;61:1295–1297.
[22] Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARSCoV-2. Int. J. Antimicrob. Agents. 2020;55(3):105923.
[23] Burley SK, Berman HM, Kleywegt GJ, Markley JL, Nakamura H, Velankar S. Protein Data Bank (PDB) The Single Global Macromolecular Structure Archive. Methods. Mol. Biol. 2017;1607:627-641.
[24] Trott O, Olson AJ. Improving the speed and accuracy of docking with a new scoring function, efficient optimization, multithreading. J. Comput. Chem. 2009;31:455−461.
[25] Ngo ST, Fang S-T, Huang S-H. Anti-Arrhythmic Medication Propafenone a Potential Drug for Alzheimer’s Disease Inhibiting Aggregation of Aβ: In Silico and In Vitro Studies. J. Chem. Inf. Model. 2016;56 (7):1344− 1356.
[26] Dennig A, Lulsdorf N, Liu HF, Schwaneberg U. Regioselective o-Hydroxylation of Monosubstituted Benzenes by P450 BM3. Angew. Chem., Int. Ed. 2013;52 (32):8459−8462.
[27] Perrier A, Eluard M, Petitjean M, Vanet A. In Silico Design of New Inhibitors Against Hemagglutinin of Influenza. J. Phys. Chem. B. 2019;123 (3):582−592
[28] Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J. Crit. Care. 2020;57:279-283.
[29] Sridhar C, Subbaraju GV, Venkateswarlu Y, Venugopal RT. New Acylated Iridoid Glucosides from Vitex altissima. J. Nat. Prod. 2004;67:2012-2016.
[30] Xiao W, Yao X, Li H, Yu Y, Wang Z, Yao Z, Dai Y, Gao H. Iridoid glycoside compound and its preparation method and application. CN104098632A. 2014;15-10.
[31] Cheng Y, Wang S, Wang Y. Iridoid compound with anti-inflammatory activity, its preparation method and application in preparing antiinflammatory medicine. CN103113432A. 2013;22-05.
[32] Yang B, Zhao H, Gu M, Song H. Preparation of iridoid ester compounds for treatment of cancer. CN104387362A. 2015;04-03.
[33] Zhang W, Lin S, Shan L, Su J, Liu R, Li H, Shen Y, Xu X. Iridoid compounds extracted from Valeriana officinalis and its application as antitumor agents. CN 101444501A. 2009;03-06.
[34] Yang H. Extraction of iridoid compound from Eucommia ulmoides for myocardial protection. CN105481820A. 2016;13-04.
[35] Yao T. A kind of new iridoid and its preparation method and medicinal use. CN105367536A. 2016;02-03.
[36] Zhang W, Su J, Lin S, Shan L, Liu R, Li H, Xu X. Application of iridoid compounds in preparation of medicine for treating ovarian cancer. CN101829080A. 2010;15-09.
[37] Wu J. Preparation of iridoid compound with endothelial cell protection effect. CN105503893A. 2016;20-04.
[38] Gautam R, Jachak SM, Saklani A. Anti-inflammatory effect of Ajuga bracteosa Wall Ex Benth. Mediated through cyclooxygenase (COX) inhibition. J. Ethnopharmacol. 2011;133:928-930.
[39] Hsieh W-T, Liu Y-T, Lin W-C. Anti-inflammatory properties of Ajuga bracteosa in vivo and in vitro study and their effects on mouse model of liver fibrosis. J. Ethnopharmacol. 2011;135:116-125.
[40] Kaithwas G, Gautam R, Jachak SM, Saklani A. Antiarthritic effects of Ajuga bracteosa Wall ex Benth. in acute and chronic models of arthritis in albino rats. Asian. Pac. J. Trop. Med. 2012;2:185-188.
[41] Vaughan JCS. A preliminary note on the use of Vitex peduncularis in malarial fever and in blackwater fever. The British Medical Journal. 1921;1:186-188.
[42] Stavri M, Mathew KT, Gibbons S. Antimicrobial constituents of Scrophularia deserti. Phytochemistry. 2006;67:1530-1533.
[43] Ahmed B, Al-Rehaily AJ, Al-Howiriny TA, El-Sayed KA, Ahmad MS. Scropolioside-D2 and Harpagoside-B: Two new iridoid glycosides from Scrophularia deserti and their antidiabetic and anti-inflammatory activity. Biol. Pharm. Bull. 2013;26:462-467.
[44] Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery. 2020;6.